In-Vitro Fertilization (IVF) Market is expected to grow at a CAGR of over 11.7% over the Forecast Period 2012-2022

Global In-Vitro Fertilization (IVF) market is expected to reach USD 27 billion by 2022, according to a new report by Grand View Research, Inc. The market is driven by the increasing incidence of infertility owing to, lifestyle changes, expansion of fertility procedures for treating male infertility such as ICSI, government initiatives to provide better reimbursement policies, and continuous efforts by the industry contributors. 

Moreover, the availability of genomic testing enabling the prevention of the transfer of genetic disease during IVF use is further expected to drive the market demand. The increase in the number of IVF treatment has led more insurance players to cover the IVF procedures. This has ultimately led to competitive pricing and has moderated the treatment costs as IVF has been a successfully practiced technology. This will most likely drive the market by introducing treatment standardization and automation. 

The behavioral shift in the society is a major factor contributing to the decreased Total Fertility Rate (TFR). These factors include an increasing number of women in the labor force, the increased age of the first birth, a shift from rural to urban societies, lower marriage rates, postponement of marriage, and greater levels of education for women. 

Obesity is another factor, which has led to an increase in infertility in the population. This is due to the fact that the fat deposited on women’s abdomen prevents follicular stimulation and produces male hormones. In the case of males, the rising fat decreases testosterone levels causing a problem in sperm production. Doctors have started recommending weight loss in men prior to fertility treatments along with proper Body Mass Index (BMI) maintenance. The U.S. Endocrine Society has established the use of Letrozole to increase the testosterone levels in obese patients. 

Full Research Report on Global In-Vitro Fertilization (IVF) Market Analysis: 
http://www.grandviewresearch.com/industry-analysis/in-vitro-fertilization-market

Further key findings from the report suggest: 

• Intracytoplasmic Sperm Injection (ICSI) dominated the market in 2014.ICSI was introduced in the year 1992 and boosted the fertility rates from 50% to 80%, according to the American Society for Reproductive Medicine. In April 2016, Nigeria recorded its first successful delivery from a frozen egg. Bridge Clinic has stored the eggs using the flash-freezing technique. With this birth, Nigeria has put itself on the global map as it now offers IVF through frozen eggs. The eggs were then fertilized using the ICSI technique. 

• Frozen Embryo Replacement (FER) technique is expected to witness a rapid rise in demand. Conventionally, most embryos were transferred through fresh cycles. However, with technology refinement, the number of frozen embryo transfers and the success rates have increased. Moreover, the policy of freezing the embryos has also reduced the chances of ovarian hyper-stimulation. The frozen embryo transfers enable single egg transfer, thus, giving enough time for the endometrial layer to heal from the medicine stimulation effect. This ensures higher success rates. 

• Culture media dominated the overall market in terms of revenue in 2014. With the increasing government funding and industrial support for employees for egg/sperm freezing, the demand for cryopreservation and the needed media for it is expected to witness growth. There has been an increase in the research activities undertaken to improve the culture media and to procure maximum boar sperms or eggs, spurring market growth. Moreover, the increasing number of egg/sperm donor banks is expected to drive the demand for sperm, egg, and embryo processing media during the forecast period. 

• Europe dominated the IVF market in 2014. High quality of treatment offered at the most economical price, and the adherence to medical standards have contributed to its market leadership. In Europe, the NHS covers three IVF cycles and has also started providing coverage for gametes freezing. Moreover, the region is an attraction for international clients as countries, such as Spain, have the highest number of egg donors. The clinics also provide sex identification and other IVF treatments, which are not offered in North America. 

• North America also accounted for a significant share of the market in 2014. The standardization of procedures through automation, regulatory reforms, government funding for egg/sperm storage, and industry players introducing more IVF treatments are some contributing factors for North America dominating the IVF market. 

• The presence of favorable reimbursement framework (implementation of USD 50 million 5-year plans by the U.S Department of Defense for sperm/egg freezing coverage) is also expected to drive regional market growth over the next six years. The increasing number of clinics undertaking newer industrial techniques to offer better fertility success rates is also expected to boost the regional market demand. 

• The demand for IVF treatment is expected to boom in APAC owing to fertility tourism, increasing foreign industries trying to penetrate the economically developing countries and the changing regulatory landscape. 

• The Asia Pacific Initiative on Reproduction (ASPIRE), the task force of clinicians and scientists is involved in the monitoring and management of fertility and Assisted Reproductive Technology (ART). Such initiatives promote awareness levels thereby, driving growth. 

• Industry contributors are introducing newer automation to shift the IVF treatment from invasive to a minimally invasive or non-invasive procedure. The industry players are also trying technologies, which can enable older women to have enhanced fertility rates. For instance, in August 2015, OvaScience announced the results of its first published analysis comparing AUGMENT fertility treatment with a standard IVF. The results showed a significantly higher rate of selection and transfer of embryos as compared to the standard treatment. 

• Some key players in this market includeEMD Serono Inc., Boston IVF, OvaScience, Thermo Fisher Scientific Inc., Vitrolife AB, Irvine Scientific, CooperSurgical, Inc., Cook Medical Inc., Genea Biomedx and Progyny Inc. 

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the Global In-Vitro Fertilization (IVF) Market on the basis of procedures, type of cycles, instruments, end-use, and regions: 

Global In-Vitro Fertilization (IVF) Procedures Outlook (Revenue, USD Million, 2012 - 2022)

• Intracytoplasmic Sperm Injection (ICSI)
• Frozen Embryo Replacement (FER)
• Pre-implantation Genetic Diagnosis (PGD)
• Others

Global In-Vitro Fertilization (IVF) Types of Cycles Outlook (Revenue, USD Million, 2012 - 2022)

• Fresh Donor
• Frozen Donor
• Fresh Non-donor
• Frozen Non-donor

Global In-Vitro Fertilization (IVF) Instruments Outlook (Revenue, USD Million, 2012 - 2022)

• IVD Disposable Devices
• Culture Media
• Capital Equipment

In-Vitro Fertilization (IVF) Regional Outlook (Revenue, USD Million, 2012 - 2022)

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Rest of Europe
• Asia Pacific
• India
• Japan
• China
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Rest of Latin America
• MEA
• South Africa
• Rest of MEA

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-ivf-market                    

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Industrial Agitators Market Analysis By Product, Application And Segment Forecast Up To 2024

Global Industrial Agitators Market is expected to reach USD 3.46 billion by 2024, according to a new report by Grand View Research, Inc. Industrial agitators market is expected to witness high growth owing to the rapid industrialization in emerging economies such as Brazil, India, and China. Increasing industrial activities in these countries are enhancing the demand for highly-efficient agitators. 

Agitators are efficiently used in the food &beverage, chemical and wastewater treatment applications. Hence, growing adoption of mixing and blending technology in process industries is projected to drive the market over the forecast period. 

Agitators are machines, which processes the products in industries for mixing liquids, increasing heat transfer and to promote the reaction of chemical substances. Demand for customized and advanced devices specific to the end-user application is further expected to drive market growth. Chemical and wastewater treatment industries have high complex agitation demand, which is further boosting the demand for these devices.

Full Research Report on Global Industrial Agitators Market:
http://www.grandviewresearch.com/industry-analysis/industrial-agitators-market

Further key findings from the report suggest:

• Top entry segment is estimated to grow at a CAGR of over 6.5% from 2016 to 2024.These agitators have long durability and offer homogenous and mixing needs of consumers as per their requirements. Moreover, increasing adoption in the chemical and oil & gas industry is boosting the overall industry growth.
• Chemical is a key application and is expected to dominate the market, growing at a CAGR of over 6.5% from 2016 to 2024. Increasing growth of chemical industry in the Asia Pacific region is projected to propel the demand for industrial agitators over the forecast period. They are used for uniform mixing of various liquids and follow rigid specifications for cleanliness, consistency, and accuracy.
• The North America industrial agitators industry is expected to remain the largest market owing to the widespread adoption of these devices in various industrial sectors. However, the regional market is highly saturated, and demand for efficient and technologically advanced agitators is increasing for replacing the existing devices. The regional industry is projected to account for over 30% by 2024, growing at a CAGR of over 6.0% from 2016 to 2024.
• Asia Pacific is expected to be the fastest-growing region owing to the growth in the industrial sector. Moreover, favorable government policies are boosting the regional demand.
• Key players in the industrial agitators market include Sulzer Ltd, Xylem Inc., EKATO Group, SPX Corporation and Philadelphia Mixing Solutions Ltd. The market is highly competitive owing to the presence of numerous manufacturers’ incorporating innovative technologies to offer product differentiation.

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/electronic-devices

Grand View Research has segmented the Global Industrial Agitators Market on the basis of equipment, and region:

Industrial Agitators Product Outlook (Revenue, USD Million, 2015 - 2024)

• Top Entry
• Side Entry
• Bottom Entry
• Portable
• Static

Industrial Agitators Application Outlook (Revenue, USD Million, 2015 - 2024)

• Chemical
• Water And Wastewater Treatment
• Oil, Gas And Petrochemical
• Food And Beverages
• Pharmaceutical
• Others

Industrial Agitators Regional Outlook (Revenue, USD Million, 2015 - 2024)

• North America
• Europe
• Asia Pacific
• RoW

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-industrial-agitators-market                   

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Industrial Adhesives Market Is Estimated To Growing At A CAGR Of 4.1% From 2015 To 2022

Global Industrial Adhesives Market is expected to reach USD 57.12 billion by 2022, according to a new report by Grand View Research, Inc. Growth of key end-use industries such as packaging, construction and automotive is expected to remain a key driving factor for global industrial adhesives market over the forecast period. 

Growing demand for eco-friendly materials has led to the development of bio-based adhesives. This trend is likely to foster replacement of conventional metal, wood and other fasteners with adhesives to bond a wide array of substrates. Increasing industrial output in emerging nations such as China, India, Brazil and Mexico has also impacted the market positively. 

Acrylics were the leading product type with demand share exceeding 40% in 2014. Increasing requirement for adhesion products with aesthetic appeal, high bond strength across dissimilar substrates and contaminated surfaces is a key determinant for industry development. They are also expected to witness the highest growth of 4.4% from 2015 to 2022. 

Full Research Report on Global Industrial Adhesives Market Analysis:
http://www.grandviewresearch.com/industry-analysis/industrial-adhesives-market

Further key findings from the report suggest:

• Global industrial adhesives market size was 9.40 million tons in 2014 and is expected to reach 12.94 million tons by 2022, growing at a CAGR of 4.1% from 2015 to 2022.
• Packaging was the leading application segment and accounted for 30.3% of total market volume in 2014. Increasing demand for quicker assembly time, high bond strength in carton sealing and corrugated box manufacturing led to high consumption in packaging industry. Packaging is also expected to witness the highest growth of 4.7% from 2015 to 2022.
• Asia Pacific was the largest consumer and accounted for 42.3% of total volume in 2014. The region is characterized by increasing consumer disposable income and high growth in packaging, construction, and automotive industries mainly in China, India and Southeast Asia.
• Developed markets of North America and Europe are characterized by growing demand for bio-based adhesives on account of growing regulatory pressure and consumer awareness. Europe is expected to witness moderate growth of 2.5% from 2015 to 2022.
• Global industrial adhesives market share is characterized by multinational corporations which are integrated along the value chain. There is considerable presence of standalone independent manufacturers, particularly with emergence of SME landscape in China. Key companies in the industry include The Dow Chemical Company, Henkel, Cytec Industries, Mitsubishi Chemicals, Lord Corporation, Avery Dennison, and Covestro (formerly Bayer MaterialScience).

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/plastics-polymers-and-resins

Grand View Research has segmented the Global Industrial Adhesive Market on the basis of product, application and region:

Global Industrial Adhesives Product Outlook (Volume, Kilo Tons; Revenue, USD Million; 2012 - 2022)

• Acrylic
• Polyvinyl Acetate
• Epoxy
• Polyurethane
• Ethyl Vinyl Acetate
• Others

Global Industrial Adhesives Application Outlook (Volume, Kilo Tons; Revenue, USD Million; 2012 - 2022)

• Automotive
• Construction
• Packaging
• Electrical & Electronics
• Energy & Utilities
• Medical Devices
• Industrial Machinery
• Others

Global Industrial Adhesives Regional Outlook (Volume, Kilo Tons; Revenue, USD Million; 2012 - 2022)

• North America
• U.S.
• Canada
• Mexico
• Europe
• UK
• Germany
• France
• Asia Pacific
• China
• India
• Japan
• Central & South America
• Brazil
•  Middle East & Africa

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-industrial-adhesives-market                  

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

In-vitro Toxicology Testing Market Is Projected To Growing At An Estimated CAGR Of 10.5% From 2015 To 2022

Global In-Vitro Toxicology Testing Market is expected to reach USD 44.7 billion by 2022 growing at an estimated CAGR of 10.5% from 2015 to 2022, according to a new report by Grand View Research, Inc. This expected rise in demand can be ascribed to novel and promising technologies in analytical laboratories. 

Advancement in bioinformatics based research for development of efficient software algorithms in order to carry out efficient stimulation of in-silico animal models in determination of toxicological response is expected to influence sector growth through to 2022. 

Furthermore, rapid up gradation of databases that serve information for toxicity profiling and lethal dose determination of different compounds is anticipated to create significant potential for growth in this market during the forecast period. 

Rise in government imposed restrictions and guidelines on usage of animals for pre-clinical research and toxicology testing is also attributive towards estimated progress in this industry.

Additionally, increasing R&D in biotechnology sector for enhancement in cell based assays and cell culture techniques, is anticipated to impart significant growth potential in this sector. 

Full Research Report on Global In-vitro Toxicology Testing Market Analysis:
http://www.grandviewresearch.com/industry-analysis/in-vitro-toxicology-testing-market

Further key findings from the study suggest:

• Pharmaceutical and cosmetic industry together accounted for almost 65% of total revenue generated in this sector for 2014. This large share can be attributed to rapid novel product launches for treatment of different diseased conditions wherein toxicological testing is the pre-requisite step. 

• Cell culture technology contributed for over 42% of the revenue generated in the industry with respect to technology owing to critical role of cell culture in biotechnological development and cell based analysis 

• Omics technology is anticipated to register lucrative growth thereby driving demand due to advancement in sequencing methods and availability of different platforms depending on source and target sequence. 

• As a fundamental process in biopharmaceutical or pharmaceutical product development toxicological testing finds application in determination of systemic, dermal, & ocular toxicity as well as endocrine disruption 

• Amongst the above enlisted applications, dermal toxicity is expected to witness significant progress with a CAGR of approximately 13% due to comparatively higher incidence of side effects associated with skin after administration of several compounds. 

• North America accounted for the largest share of over 45% in revenue in 2014 owing to presence of significant number of sector players that are implementing advanced in-vitro technology. Furthermore, presence of stringent regulations pertaining to animal usage in toxicity analysis attributive towards high demand of in-vitro tests in this region. 

• Asia Pacific is expected to witness lucrative CAGR of over 11% from 2015 to 2022 due to rapid improvement in health care infrastructure in developing economies of this region which in turn contributes to regional progress in industry. 

• Key participants of in-vitro toxicology testing industry are Quest Diagnostics, Covance, Cyprotex, Alere, Inc, Charles River Laboratories, GE Healthcare, Thermo Fisher Scientific, Eurofins Scientific, Inc., Agilent Technologies, Catalent Pharma Solutions, Sigma Aldrich, and Bio-Rad. 

• These participants are involved in collaborations with bioinformatics research firms in order to develop novel in-silicoalgorithms for computational estimation of toxicity of pharmaceutical and chemical products. 

• Moreover, these market entities are also focusing on entering untapped regions in order to maintain their share in market revenue. 

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/clinical-diagnostics

Grand View Research has segmented Global In-Vitro Toxicology Testing Market on the basis of end use, technology, method, application, and region:

Global In-vitro Toxicology Testing Outlook, by End-use (Revenue, USD Million, 2012 - 2022)

• Pharmaceutical industry
• Cosmetics & household products
• Diagnostics
• Chemical industry
• Food industry

Global In-vitro Toxicology Testing Technology Outlook (Revenue, USD Million, 2012 - 2022)

• Cell culture technology
• High throughput technology
• Molecular imaging
• OMICS technology

Global In-vitro Toxicology Testing Outlook, by Application (Revenue, USD Million, 2012 - 2022)

• Systemic Toxicology
• Dermal Toxicity
• Endocrine Disruption
• Occular toxicity

Global In-vitro Toxicology Testing Outlook, by Method (Revenue, USD Million, 2012 - 2022)

• Cellular Assay
• Biochemical Assay
• In-Silico
• Ex-vivo

In-vitro Toxicology Testing Regional Outlook (Market Revenue in USD Million, 2012 - 2022 )

• North America
• Europe
• Asia Pacific
• RoW

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-in-vitro-toxicology-testing-market                 

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

In Vitro Diagnostics (IVD) Quality Control Market Is Expected To Grow At A CAGR Of 3.7% During The Forecast Period 2014-2025

Global IVD Quality Control Market is expected to reach over USD 1.13 billion by 2024 according to a new report by Grand View Research, Inc.

The continually evolving technology-oriented changes in the diagnostics field and the growing requirement to ensure patient safety necessitate the implementation of quality assurance programs in various medical disciplines including radiology and point-of-care devices.

The patients rely on self-testing IVD devices for long-term disease management and hence it is important for such IVD devices to be checked for quality in terms of result reproducibility and validity in order to guarantee patient safety. The rising number of certified clinical laboratories offering dependable IVD-based diagnostic services directly correlates with increased patient confidence, thus driving the quality control market.

In addition to quality assessments, amendments to the regulatory framework are made intermittently to enhance the present quality standards with the main objective of safeguarding qualitative superiority of the diagnostic services rendered to patients.

In May 2016, the European Union passed an agreement to update the pre-existing regulations pertaining to IVD devices wherein the updates were in concern with raising the patient safety levels, particularly for disabled persons. Furthermore, the presence of third party quality control agencies for independent assessment of the IVD devices is expected to elevate the current safety standards, which is expected to further propel the market growth.

Full Research Report on Global In Vitro Diagnostics (IVD) Quality Control Market Analysis:
http://www.grandviewresearch.com/industry-analysis/in-vitro-diagnostics-ivd-quality-control-market

Further key findings from the study suggest:

• In 2015, the clinical chemistry segment dominated the IVD quality control market with a share of over 35%. The increasing demand for preventive medicine and the rapid transformation of clinical laboratories into highly automated and efficient businesses are some of the factors for its large market share.
• The molecular diagnostics is one of the fastest growing segments during the forecast period owing to the increasing technical complexity of molecular diagnostic testing coupled with the constant need for quality evaluation to ensure standards. The molecular diagnostics tests are of prime importance as the test outcomes enable healthcare practitioners make critical treatment decisions.
• The hospital segment held the largest share in 2015 due to the presence of highly advanced technology-based devices, such as Next Generation Sequencing (NGS), mass spectrophotometry, and microarrays, and the rising applications of the optimized quality-control procedures
• The North America contributed over 43% of the market share in 2015 attributable to the presence of over 150,000 registered diagnostics laboratories. The clinical laboratories are required to provide accurate results and maintain the accuracy standards in order to retain their license to operate.
• Many pharmaceutical companies are implementing the new draft guidance enforced by the U.S. FDA for data integrity on current Good Manufacturing Practices (cGMP).It provides information in relation to establishing robust operating procedures and strong quality management systems, obtaining high-quality raw materials, investigating quality deviations, and maintaining reliable diagnostic laboratories

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the IVD quality control market on the basis of application, type, end-use, and region:

IVD Quality Control Market Application Outlook, by Revenue (USD Million, 2013 - 2024)

• Clinical Chemistry
• Immunochemistry
• Hematology
• Molecular Diagnostics
• Coagulation
• Microbiology
• Others

IVD Quality Control Market Type Outlook, by Revenue (USD Million), 2013 - 2024

• Quality Controls
• Plasma-based Controls
• Serum-based Controls
• Whole Blood-based Controls
• Other IVD Quality Controls
• Data Management
• Quality Assurance Services

IVD Quality Control Market End-use Outlook, by Revenue (USD Million), 2013 - 2024

• Home-care
• Laboratory
• Hospitals
• Others

IVD Quality Control Market Regional Outlook, by Revenue (USD Million), 2013 - 2024

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• Japan
• China
• Latin America
• Brazil
• MEA
• South Africa

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-in-vitro-diagnostics-ivd-quality-control-market                

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Immunoprotein Diagnostic Testing Market Analysis By Type, Technology, Application, And Segment Forecast Up To 2025

Global Immunoprotein Diagnostic Testing Market is anticipated to reach USD 10.3 billion by 2025, according to a new report by Grand View Research, Inc. This growth can be attributed to the rising incidence of chronic diseases.

According to American Heart Association’s 2017 statistics, nearly 790,000 people experience heart attack every year in the U.S. In addition, stroke is responsible for 1 in every 20 deaths in the U.S. Hence, WHO is also taking initiatives to reduce the risk of cardiovascular diseases. As a result of the aforementioned factors, the demand for immunoprotein diagnostics is expected to rise in order to facilitate rapid diagnosis.

According to WHO, nearly 1.69 million deaths due to lung cancer were registered in 2015 throughout the world. Hence, fast and accurate diagnosis of such chronic diseases has become important to reduce the high mortality rate. Immunoprotein diagnostic devices and reagents have proved to be highly effective in rapidly detecting chronic diseases.

Technological advancements in the field of immunoprotein diagnostics have led to introduction of novel products. For instance, LIAISON XL, manufactured by DiaSorin, is a fully automated chemiluminescence analyzer that facilitates complete sample processing. It also measures and evaluates testing samples, thereby, enhancing the efficiency and throughput of the system.

Full Research Report On Global Immunoprotein Diagnostic Testing Market Analysis:
http://www.grandviewresearch.com/industry-analysis/immunoprotein-diagnostic-testing-industry

Further key findings from the study suggest:

• In 2016, immunoglobulin tests dominated the market owing to their frequent usage by healthcare professionals for diagnosing infectious or autoimmune disorders
• C-Reactive Protein (CRP) tests held a significant market share in 2016 due to the broad product portfolio of these assays and reagents
• Infectious disease testing held largest market share in 2016 owing to the increasing prevalence of infectious diseases and high applications of immunoprotein tests
• Enzyme-based immunoassays dominated the market in 2016 due to their frequent usage and availability of large number of products that possess this technology
• Chemiluminescence assay is anticipated to witness highest growth over the forecast period due to its high sensitivity and specificity
• North America dominated the market in 2016 due to rising prevalence of cancer & increase in mortality due to cancer-related diseases and favorable healthcare reimbursement scenario in the U.S.
• Some of the key players are Bio-Rad Laboratories, Inc.; F. Hoffmann-La Roche AG; Abbott Laboratories; Enzo Biochem, Inc.; Thermo Fisher Scientific, Inc.; DiaSorin S.p.A; bioMérieux SA; and Siemens Healthcare GmbH

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the Global immunoprotein diagnostic testing market on the basis of test type, application, technology, and region:

Immunoprotein Diagnostic Testing Test Type Outlook (Revenue, USD Million, 2014 - 2025)

• Complement System Proteins Diagnostic Tests
• Free Light Chain Diagnostic Tests
• Haptoglobin Diagnostic Tests
• Immunoglobulin Diagnostic Tests
• Prealbumin Diagnostic Tests
• C-Reactive Protein (CRP) Diagnostic Tests 

Immunoprotein Diagnostic Testing Application Outlook (Revenue, USD Million, 2014 - 2025)

• Infectious Disease Testing
• Oncology Testing
• Endocrine Testing
• Toxicology Testing
• Allergy Testing
• Autoimmune Disease Testing

Immunoprotein Diagnostic Testing Technology Outlook (Revenue, USD Million, 2014 - 2025)

• Radioimmunoassay
• Enzyme-based Immunoassay
• Chemiluminescence Assay
• Immunofluorescence Assay
• Immunoturbidity Assay
• Immunoprotein Electrophoresis

Immunoprotein Diagnostic Testing Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Asia Pacific
• Japan
• China
• India
• Latin America
• Brazil
• Mexico
• MEA
• South Africa
• Saudi Arabia

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-immunoprotein-diagnostic-testing-market               

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Structural Foam Market Is Expected To Witness Growth At 5.8% CAGR During Forecast Period 2014-2025

Global Structural Foam Market is expected to reach USD 42.2 billion by 2025, according to a new report by Grand View Research, Inc.  The market is expected to witness growth at 5.8%CAGR owing to Increasing infrastructure spending, particularly on residential & commercial buildings, has been a key factor driving the market growth. Moreover, the rising demand from material handling, automobile, and electrical & electronics, is also likely to contribute to the product demand over the forecast period. 

Increasing construction spending, particularly in emerging markets of Brazil, China, India, Mexico, Russia, and South Africa is expected to drive injection molded structural foam demand in these regions. Besides, positive outlook of the global automotive and packaging industries coupled with versatile properties of structural foams including better heat and pressure resistance increases their application scope in various industries.

However, volatility in prices of essential raw materials along with the growing environmental issues concerning their disposal is anticipated to hamper the market growth during the forecast period. On account of these concerns, many of the industry participants are aiming to develop bio-based foams using the injection molding technique.

Key market players such as SABIC, One Plastic Group, and Covestro AG are among the companies involved in the production and distribution of the products and have established themselves as key market participants and have high integration throughout the value chain. 

Full Research Report on Global Structural Foam Market Analysis:
http://www.grandviewresearch.com/industry-analysis/structural-foam-market

Further key findings from the report suggest:

• The global structural foam demand was 4,059.0 kilo tons in 2016 and is projected to grow at a CAGR of 5.3% from 2017 to 2025
• Polyethylene foam segment was the largest product segment in 2016 and is expected to generate revenue over USD 15.62 billion by 2025
• Global structural foam in automotive segment was valued at USD 6.81 billion in 2016 and is projected to witness a growth at a CAGR of 6.2% over the forecast period
• The U.S. structural foam market in building & construction was 518.8 kilo tons in 2016 and is likely to reach an overall volume of 851.6 tons by 2025
• The market in Asia Pacific is anticipated to witness considerable growth over the next few years owing to various advances across key regions, especially in the India and China. In terms of revenue, the regional market is likely to grow at a CAGR of 6.4% from 2017 to 2025
• Key market participants include Armacell International S.A., BASF, Diab International AB, The Dow Chemical Company, SABIC, One Plastic Group, Covestro AG, Evonik Industries and others.

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry-analysis/structural-foam-market

Grand View Research has segmented the Global Structural Foam Market on the basis of product, application, and region:

Structural Foam Product Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2025)

• Polyethylene
• Polypropylene
• Polystyrene
• Polyurethane
• Others

Structural Foam Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2025)

• Material Handling
• Building & Construction
• Automotive
• Electrical & Electronics
• Others

Structural Foam Regional Outlook (Volume, Kio Tons; Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Europe
• Germany
• UK
• France
• Asia Pacific
• China
• India
• Japan
• Central & South America
• Middle East & Africa 

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-structural-foam-market              

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com